PlainRecalls
ModerateClass IIOngoing

FDA Drug recall · Reported August 5, 2026

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).

Presence of precipitate

Recall #
D-0734-2026
Affected scope
5688 vials
Initiated
July 2, 2026
Verify with FDA Drug →
View my saved recalls

Mylan Pharmaceuticals INC recalled Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carto… - a moderate-severity action.

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carto… was recalled by Mylan Pharmaceuticals INC in August 5, 2026. Reason: Presence of precipitate. Check the official notice for the remedy. Verify recall #D-0734-2026 with the FDA Drug before acting.

The recall

Mylan Pharmaceuticals INC issued this moderate-severity FDA Drug recall-Presence of precipitate.

Moderate
severity level
Class II
classification
August 5, 2026
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0734-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0734-2026) was formally reported on August 5, 2026, with the manufacturer initiating the action on July 2, 2026. It is classified under Moderate severity (Class II), with a current status of Ongoing. Mylan Pharmaceuticals INC is listed as the recalling firm, operating out of Morgantown, WV. Federal records list the affected scope as 5688 vials.

The documented reason for this recall is: Presence of precipitate Distribution data in the federal record shows the product reached: USA Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,472 drugs & medications recalls on record

05001,0001,5002,000 2006201220152018202120242026 448
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).

Reason for recall

Presence of precipitate

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number D-0734-2026
Date reported August 5, 2026
Date initiated July 2, 2026
Recalling firm Mylan Pharmaceuticals INC
Firm location Morgantown, WV
Affected scope 5688 vials
Distribution USA Nationwide

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0734-2026) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).. Recalled by Mylan Pharmaceuticals INC. Units affected: 5688 vials.
Why was this product recalled?
Presence of precipitate
Which agency issued this recall?
This recall was issued by the FDA Drug on August 5, 2026. Severity: Moderate. Recall number: D-0734-2026.
Where was the recalled product distributed?
Distribution: USA Nationwide.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported August 5, 2026. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026